Work

Effect of the loss of the type III TGFβ receptor during tumor progression on tumor microenvironment: Preclinical development of TGFβ inhibition and TGFβ-related biomarkers to enhance immunotherapy efficacy.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.10563

Authors: Brent Allen Hanks, Alisha Holtzhausen, Petra Gimpel, Rebekah Jamieson, Olivia M. Campbell, Lihong Sun, Christina K. Augustine, Douglas S. Tyler, Takuya Osada, Michael Morse, Leona E. Ling, H. Kim Lyerly, Gerard C. Blobe

Institutions: Duke Medical Center, Duke University, Freie Universität Berlin, Biogen (United States)

Language: English

Topic: TGF-β signaling in diseases

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2782207381

Cites:

Cited by: 4

Related to: 10